C端结合蛋白2是一种新型瘤抑制剂,向多发性髓瘤中MYC-IRF4轴
Coty Hing Yau Cheung1, Chi Keung Cheng1, Kam Tong Leung2
1Blood Cancer Cytogenetics and Genomics Laboratory, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
Blood advances
|March 8, 2024
概括
在多发性骨髓瘤中,C-终端结合蛋白2 (CTBP2) 通过抑制MYC-IRF4轴,起到瘤抑制作用. 恢复CTBP2显示出强大的抗髓瘤作用,并为这种MYC/IRF4成癌症提供了一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 多发性骨髓瘤 (MM) 细胞依赖MYC和IRF4生存,但这些被认为是不可抗药的目标.
- 目前对MM的治疗策略面临挑战,原因是小分子抑制剂的效率低和非目标效应.
研究的目的:
- 研究C端结合蛋白2 (CTBP2) 在多发性髓瘤中的作用.
- 探索CTBP2作为一种潜在的治疗点,用于抑制MM中的MYC-IRF4轴.
主要方法:
- 研究了MM患者样本中的CTBP2表达水平,并将其与临床结果相关联.
- 利用体外和体内模型来评估CTBP2恢复的抗髓瘤效应.
- 研究了CTBP2作用的分子机制,包括表观遗传修饰 (H3K27ac) 和MYC,IRF4和IFIT3.3的调节.
- 评估了表观遗传药物在恢复CTBP2表达方面的疗效.
主要成果:
- 在MM中,CTBP2经常下调,与生存率低下和超增殖有关.
- 恢复CTBP2在体外和体内表现出对MM细胞显著的抗瘤活性.
- CTBP2通过H3K27脱乙和抑制剂IFIT3.3的激活来抑制MYC和IRF4转录.
- 表观遗传修饰剂 (EZH2,HDAC,DNMT抑制剂) 有效地恢复了MM中的CTBP2表达.
结论:
- 在多发性骨髓瘤的发展中,CTBP2的丧失至关重要,并且与MYC-IRF4失调有关.
- 通过抑制MYC-IRF4轴,CTBP2充当瘤抑制剂,并具有免疫调节功能.
- 针对CTBP2,可能通过表观遗传疗法,是治疗MYC/IRF4成多发性骨髓瘤的一个有希望的策略.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K


